Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today and set a price target ...

The World Bank has urged the Federal Government to address key constraints hindering private sector growth in Nigeria, stating that reforms in critical sectors could unlock billions of dollars in ...

Japan’s drug pricing scheme has gotten more complicated, and pharma companies should brace themselves for annual price cuts.

Climate change and efforts to curb it by moving away from fossil fuels are both threatening the rights and livelihood of Sami indigenous people in the Arctic, Amnesty International said Friday. There ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

Continuing the annual tradition, Samsung held its grand Unpacked event to launch the Galaxy S25 series, which includes Galaxy S25 Ultra, Galaxy S25+ and Galaxy S25. At the event, Samsung showcased the ...

PCB Dismisses Concerns, Says Preparations Are ‘On Schedule’ Despite the challenges, PCB spokesperson Sami Ul Hasan remains optimistic. Speaking in a recent media briefing, he assured the public that ...

The 2025 30-Man Royal Rumble match has just added another big name to the lineup, as Sami Zayn declared himself to officially be one of this year's entrants. Joining a list of CM Punk, Drew McIntyre, ...

The January 20 episode of WWE Raw on Netflix saw backstage ambushes, in-ring chaos and a fired-up CM Punk putting the rest of the Royal Rumble lineup on blast. Here's The Big Lead's quickfire ...

Sami Zayn's promo largely served the same purpose on Monday night. It was filled with intensity and passion — even if it doesn't seem likely that Zayn makes his way into the ever-crowded main ...

LONDON, Jan 21 (Reuters) - President Donald Trump is pulling the U.S. out of the World Health Organization, raising concerns about the U.N. agency's ability to fight diseases and respond to ...

In another Chinese newco out-licensing deal, Innocare Pharma Ltd. and Keymed Biosciences Co. Ltd. out-licensed their co-developed CD20×CD3 bispecific antibody (ICP-B02/CM355) to startup Prolium ...